Richard Wilson Peck (Richard Peck, Richard W Peck)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Topics

Urinary Tract Infection

Machine Learning

Low Birth Weight

Top Venues

Clinical pharmacology and therapeutics

CPT: pharmacometrics & systems pharmacology

BMJ (Clinical research ed.)

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Iris K Minichmayr, Tomoyuki Mizuno, Srijib Goswami, Richard Wilson Peck, Thomas M Polasek, null null
Recent Advances Addressing the Challenges of Precision Dosing. Clinical pharmacology and therapeutics 116 (3) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Alicia Curth, Richard Wilson Peck, Eoin F McKinney, James Weatherall, Mihaela van der Schaar
Using Machine Learning to Individualize Treatment Effect Estimation: Challenges and Opportunities. Clinical pharmacology and therapeutics 115 (4) (2024)
Thomas M Polasek, Richard Wilson Peck
Beyond Population-Level Targets for Drug Concentrations: Precision Dosing Needs Individual-Level Targets that Include Superior Biomarkers of Drug Responses. Clinical pharmacology and therapeutics 116 (3) (2024)
Iris K Minichmayr, Tomoyuki Mizuno, Srijib Goswami, Richard Wilson Peck, Thomas M Polasek, null null
Recent Advances Addressing the Challenges of Precision Dosing. Clinical pharmacology and therapeutics (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Alicia Curth, Richard Wilson Peck, Eoin F McKinney, James Weatherall, Mihaela van der Schaar
Using Machine Learning to Individualize Treatment Effect Estimation: Challenges and Opportunities. Clinical pharmacology and therapeutics 115 (4) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Thomas M Polasek, Richard Wilson Peck
Beyond Population-Level Targets for Drug Concentrations: Precision Dosing Needs Individual-Level Targets that Include Superior Biomarkers of Drug Responses. Clinical pharmacology and therapeutics (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Alicia Curth, Richard Wilson Peck, Eoin F McKinney, James Weatherall, Mihaela van der Schaar
Using Machine Learning to Individualize Treatment Effect Estimation: Challenges and Opportunities. Clinical pharmacology and therapeutics 115 (4) (2024)
Benjamin Ribba, Richard Wilson Peck, Lucy Hutchinson, Imein Bousnina, Dario Motti
Digital Therapeutics as a New Therapeutic Modality: A Review from the Perspective of Clinical Pharmacology. Clinical pharmacology and therapeutics (2023)
Kamilė Stankevičiūtė, Jean Baptiste Woillard, Richard Wilson Peck, Pierre Marquet, Mihaela van der Schaar
Bridging the Worlds of Pharmacometrics and Machine Learning. Clinical pharmacokinetics (2023)
Alicia Curth, Richard Wilson Peck, Eoin McKinney, James Weatherall, Mihaela van der Schaar
Using Machine Learning to Individualize Treatment Effect Estimation: Challenges and Opportunities. Clinical pharmacology and therapeutics (2023)
Christina Yap, Olga Solovyeva, Johann S de Bono, Jan Rekowski, Dhrusti Patel, Thomas F Jaki, Adrian P Mander, Thomas R Jeffry Evans, Richard Wilson Peck, Kathryn S Hayward, Sally Hopewell, Moreno Ursino, Khadija Rerhou Rantell, Melanie Jane Calvert, Shing Lee, Andrew Kightley, Deborah Ashby, An-Wen Chan, Elizabeth Garrett-Mayer, John Dudley Isaacs, Robert Golub, Olga Kholmanskikh, Dawn P Richards, Oliver Boix, James Matcham, Lesley Seymour, Susan Percy Ivy, Lynley V Marshall, Antoine Hommais, Rong Liu, Yoshiya Tanaka, Jordan D Berlin, Aude Espinasse, Munyaradzi Dimairo, Christopher J Weir
Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance. BMJ (Clinical research ed.) 383 (2023)
D Max Smith, Iris K Minichmayr, Joseph F Standing, Kathleen M Giacomini, Piet H van der Graaf, Richard Wilson Peck
Ensuring Transparency and Quality of Clinical Trial Reporting in Clinical Pharmacology & Therapeutics: Prospective Trial Registration and Compliance with Reporting Guidelines Are Required for all Clinical Trials. Clinical pharmacology and therapeutics 114 (6) (2023)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William W Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology (2023)
Christopher A Darlow, Neil John Parrott, Richard Wilson Peck, William Hope
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. CPT: pharmacometrics & systems pharmacology (2023)
Christina Yap, Jan Rekowski, Moreno Ursino, Olga Solovyeva, Dhrusti Patel, Munyaradzi Dimairo, Christopher J Weir, An-Wen Chan, Thomas F Jaki, Adrian P Mander, Thomas R Jeffry Evans, Richard Wilson Peck, Kathryn S Hayward, Melanie Jane Calvert, Khadija Rerhou Rantell, Shing Lee, Andrew Kightley, Sally Hopewell, Deborah Ashby, Elizabeth Garrett-Mayer, John Dudley Isaacs, Robert Golub, Olga Kholmanskikh, Dawn P Richards, Oliver Boix, James Matcham, Lesley Seymour, Susan Percy Ivy, Lynley V Marshall, Antoine Hommais, Rong Liu, Yoshiya Tanaka, Jordan D Berlin, Aude Espinasse, Johann S de Bono
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance. BMJ (Clinical research ed.) 383 (2023)
Alicia Curth, Richard Wilson Peck, Eoin F McKinney, James Weatherall, Mihaela van der Schaar
Using Machine Learning to Individualize Treatment Effect Estimation: Challenges and Opportunities. Clinical pharmacology and therapeutics (2023)
Alexander Chan, Richard Wilson Peck, Megan Gibbs, Mihaela van der Schaar
Synthetic Model Combination: A new machine learning method for pharmacometric model ensembling. CPT: pharmacometrics & systems pharmacology (2023)
Benjamin Ribba, Dominic Stefan Bräm, Paul Gabriel Baverel, Richard Wilson Peck
Model enhanced reinforcement learning to enable precision dosing: A theoretical case study with dosing of propofol. CPT: pharmacometrics & systems pharmacology 11 (11) (2022)
Benjamin Ribba, Sherri Dudal, Thierry Lavé, Richard Wilson Peck
Model-Informed Artificial Intelligence: Reinforcement Learning for Precision Dosing. Clinical pharmacology and therapeutics 107 (4) (2020)
Richard Wilson Peck
The pharmaceutical industry needs more clinical pharmacologists. British journal of clinical pharmacology 83 (11) (2017)